Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Zileuton> ?p ?o. }
Showing items 1 to 77 of
77
with 100 items per page.
- Zileuton abstract "Zileuton (trade name ZYFLO) is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation. Zileuton is used for the maintenance treatment of asthma. Zileuton was introduced in 1996 by Abbott Laboratories and is now marketed in two formulations by Cornerstone Therapeutics Inc. under the brand names ZYFLO and ZYFLO CR. The original immediate-release formulation of zileuton, known as ZYFLO, is taken four times per day. The extended-release formulation, ZYFLO CR, is taken twice daily. Although the extended release formulation of zileuton is still available (Zyflo CR), the immediate release tablet was withdrawn from the U.S. market on February 12, 2008.".
- Zileuton atcPrefix "none".
- Zileuton casNumber "111406-87-2".
- Zileuton chEBI "10112".
- Zileuton drugbank "DB00744".
- Zileuton fdaUniiCode "V1L22WVE2S".
- Zileuton iupacName "N-​[1-​(1-​benzothien-​2-​yl)​ethyl]-​N-​hydroxyurea".
- Zileuton pubchem "60490".
- Zileuton thumbnail (±)-Zileuton_Enantiomers_Structural_Formulae.png?width=300.
- Zileuton wikiPageExternalLink drugInfo.cfm?id=4821.
- Zileuton wikiPageExternalLink www.zyflo.com.
- Zileuton wikiPageID "1045561".
- Zileuton wikiPageRevisionID "593350272".
- Zileuton atcPrefix "none".
- Zileuton bioavailability "Not yet established".
- Zileuton c "11".
- Zileuton casNumber "111406".
- Zileuton chebi "10112".
- Zileuton chembl "93".
- Zileuton chemspiderid "54531".
- Zileuton drugName "Zileuton".
- Zileuton drugbank "DB00744".
- Zileuton eliminationHalfLife "9000.0".
- Zileuton excretion Kidney.
- Zileuton h "12".
- Zileuton hasPhotoCollection Zileuton.
- Zileuton imagename "1".
- Zileuton inchi "1".
- Zileuton inchikey "MWLSOWXNZPKENC-UHFFFAOYAH".
- Zileuton iupacName "N-​[1-​​ethyl]-​N-​hydroxyurea".
- Zileuton kegg "D00414".
- Zileuton legalUs "Rx-only".
- Zileuton medlineplus "a697013".
- Zileuton metabolism "Hepatic".
- Zileuton molecularWeight "236.291".
- Zileuton n "2".
- Zileuton o "2".
- Zileuton pregnancyUs "C".
- Zileuton proteinBound "93.0".
- Zileuton pubchem "60490".
- Zileuton routesOfAdministration "Oral".
- Zileuton s "1".
- Zileuton smiles "O=CNCC".
- Zileuton stdinchi "1".
- Zileuton stdinchikey "MWLSOWXNZPKENC-UHFFFAOYSA-N".
- Zileuton tradename "Zyflo".
- Zileuton unii "V1L22WVE2S".
- Zileuton verifiedrevid "470635835".
- Zileuton width "270".
- Zileuton subject Category:Benzothiophenes.
- Zileuton subject Category:Leukotriene_pathway_inhibitors.
- Zileuton type Inhibitor114724436.
- Zileuton type LeukotrienePathwayInhibitors.
- Zileuton type Matter100020827.
- Zileuton type PhysicalEntity100001930.
- Zileuton type Substance100020090.
- Zileuton type Drug.
- Zileuton type DrugProduct.
- Zileuton type FunctionalSubstance.
- Zileuton comment "Zileuton (trade name ZYFLO) is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation. Zileuton is used for the maintenance treatment of asthma. Zileuton was introduced in 1996 by Abbott Laboratories and is now marketed in two formulations by Cornerstone Therapeutics Inc. under the brand names ZYFLO and ZYFLO CR. The original immediate-release formulation of zileuton, known as ZYFLO, is taken four times per day.".
- Zileuton label "Zileuton".
- Zileuton label "Zileuton".
- Zileuton label "Zileutone".
- Zileuton label "Zileutón".
- Zileuton sameAs Zileuton.
- Zileuton sameAs Zileutón.
- Zileuton sameAs Zileutone.
- Zileuton sameAs m.0416gm.
- Zileuton sameAs Q202998.
- Zileuton sameAs Q202998.
- Zileuton sameAs zileuton.
- Zileuton sameAs DB00744.
- Zileuton sameAs Zileuton.
- Zileuton wasDerivedFrom Zileuton?oldid=593350272.
- Zileuton depiction (±)-Zileuton_Enantiomers_Structural_Formulae.png.
- Zileuton isPrimaryTopicOf Zileuton.
- Zileuton name "Zileuton".